Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Treasury Shares (2022 - 2025)

Historic Treasury Shares for GoHealth (GOCO) over the last 4 years, with Q3 2025 value amounting to $9.3 million.

  • GoHealth's Treasury Shares rose 12502.42% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 12502.42%. This contributed to the annual value of $4.1 million for FY2024, which is 5719.7% up from last year.
  • GoHealth's Treasury Shares amounted to $771000.0 in Q3 2025, which was up 14169.28% from $752000.0 recorded in Q2 2025.
  • In the past 5 years, GoHealth's Treasury Shares registered a high of $771000.0 during Q3 2025, and its lowest value of $11000.0 during Q1 2022.
  • In the last 4 years, GoHealth's Treasury Shares had a median value of $173000.0 in 2023 and averaged $239400.0.
  • In the last 5 years, GoHealth's Treasury Shares skyrocketed by 68039.22% in 2024 and then skyrocketed by 3880.51% in 2025.
  • GoHealth's Treasury Shares (Quarter) stood at $345000.0 in 2022, then skyrocketed by 665.22% to $2.6 million in 2023, then skyrocketed by 57.2% to $4.1 million in 2024, then soared by 123.61% to $9.3 million in 2025.
  • Its Treasury Shares was $9.3 million in Q3 2025, compared to $9.2 million in Q2 2025 and $5.0 million in Q1 2025.